Cover Image
市場調查報告書

思覺失調症治療藥「Bitopertin」的長期預測模式

BCC Research Bitopertin Forecast: Long Term Forecasting Model for Schizophrenia Drug Bitopertin

出版商 BCC Research 商品編碼 309660
出版日期 內容資訊 英文
訂單完成後即時交付
價格
Back to Top
思覺失調症治療藥「Bitopertin」的長期預測模式 BCC Research Bitopertin Forecast: Long Term Forecasting Model for Schizophrenia Drug Bitopertin
出版日期: 2014年08月01日 內容資訊: 英文
簡介

本報告提供思覺失調症治療藥「Bitopertin」的需求調查,需求規模(患者數)及需求額(美金)之各主要國家彙整資料。

調查內容

  • Bitopertin®的年度需求預測
    • 需求規模(患者數)
    • 需求額(美金)
  • 地區區分
    • 美國
    • 日本
    • 法國
    • 德國
    • 義大利
    • 英國

目錄

  • 圖:摘要圖表:需求額、需求規模的預測
  • 表格:整體市場:需求額、需求規模的各地區預測
  • 表格:美國的患者數的變化與預測
  • 表格:日本的患者數的變化與預測
  • 表格:法國的患者數的變化與預測
  • 表格:德國的患者數的變化與預測
  • 表格:義大利患者數的變化與預測
  • 表格:西班牙的患者數的變化與預測
  • 表格:英國的患者數的變化與預測
  • 表格:美國的人口和年齡層的變化與預測
  • 表格:歐洲的人口的預測:各國
  • 表格:日本的人口的預測
  • 表格:美國的藥價和FX比率的預測
  • 表格:日本的藥價和FX比率的預測
  • 表格:法國的藥價和FX比率的預測
  • 表格:德國的藥價和FX比率的預測
  • 表格:義大利的藥價和FX比率的預測
  • 表格:西班牙的藥價和FX比率的預測
  • 表格:英國的藥價和FX比率的預測
目錄
Product Code: FMO003A

With BCC Research's Bitopertin® Forecast, you will have quantitative data about forecasted revenue for the pharmaceutical drug bitopertin®, currently in development, that will guide you in your strategic decision-making regarding future participation in this product sector.

The BCC Research Bitopertin® Forecast is a quantitative forecast model in an easily accessible Microsoft® Excel® spreadsheet, segmented by specific parameters. It features:

  • Market demand forecasts for Bitopertin® annually for the years 2016 to 2030 by volume (number of patients) and value (in U.S. dollars), should the drug be licensed
  • Segmentation of volume and value for these regions:
    • United States
    • Japan
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
  • Data transparency and sources disclosed for:
    • Patient volumes, with forecasts by age range and prevalence, as well as population estimates
    • Product pricing forecasts

Use the BCC Research Bitopertin® Forecast to:

  • Examine forecasted market demand for Bitopertin®
  • Validate other Bitopertin® market-demand data to which you have access
  • Make strategic decisions about entering Bitopertin®-related or schizophrenia treatment-related markets

Bitopertin® is a drug under development intended to be used in combination with antipsychotic medications for the treatment of persistent negative symptoms or sub-optimally controlled positive symptoms associated with schizophrenia.

Table of Contents

  • Figure 1: Summary Graphs - Value in U.S.D. and Patient Volumes, by Region, 2016-2030
  • Table 1: Total Market - Value in U.S.D. and Patient Volumes, by Region, 2016-2030
  • Table 2: United States Patient Volumes, 2010-2030
  • Table 3: Japan Patient Volumes, 2010-2030
  • Table 4: France Patient Volumes, 2010-2030
  • Table 5: Germany Patient Volumes, 2010-2030
  • Table 6: Italy Volumes, 2010-2030
  • Table 7: Spain Patient Volumes, 2010-2030
  • Table 8: UK Patient Volumes, 2010-2030
  • Table 9: United States Population by age range, 2010-2012; and 2015 to 2060
  • Table 10: Europe Population by Country, 2010-2030
  • Table 11: Japan Population, 2010-2030
  • Table 12: US Pricing and FX Rate, 2016-2030
  • Table 13: Japan Pricing and FX rate, 2016-2030
  • Table 14: France Pricing and FX rate, 2016-2030
  • Table 15: Germany Pricing and FX rate, 2016-2030
  • Table 16: Italy Pricing and FX rate, 2016-2030
  • Table 17: Spain Pricing and FX rate, 2016-2030
  • Table 18: UK Pricing and FX rate, 2016-2030
Back to Top